| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Yoland Smith, Rosa Villalb. Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and Parkinsonian brains. Movement disorders : official journal of the Movement Disorder Society. vol 23 Suppl 3. 2009-02-13. PMID:18781680. |
the importance and specificity of dopamine in regulating morphological changes in striatal projection neurons provides further evidence for the complex and multifarious mechanisms through which dopamine mediates its functional effects in the basal ganglia. |
2009-02-13 |
2023-08-12 |
Not clear |
| Yoland Smith, Rosa Villalb. Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and Parkinsonian brains. Movement disorders : official journal of the Movement Disorder Society. vol 23 Suppl 3. 2009-02-13. PMID:18781680. |
in this review, the role of basal ganglia dopamine and its functional relevance in normal and pathological conditions will be discussed. |
2009-02-13 |
2023-08-12 |
Not clear |
| Ahmed A Moustafa, Scott J Sherman, Michael J Fran. A dopaminergic basis for working memory, learning and attentional shifting in Parkinsonism. Neuropsychologia. vol 46. issue 13. 2009-02-03. PMID:18687347. |
these results lend further insight into the role of basal ganglia dopamine in wm and broadly support predictions from neurocomputational models. |
2009-02-03 |
2023-08-12 |
Not clear |
| I Vernaleken, P Cumming, G Gründe. Imaging studies - differential action of typical and atypical antipsychotics in a network perspective. Pharmacopsychiatry. vol 41 Suppl 1. 2009-02-03. PMID:18756422. |
we now summarize the state of development of molecular imaging, integrated into a model of schizophrenia emphasizing dysfunction of a complex loop, rather than a discrete abnormality in the basal ganglia, as had been implicitly assumed in the classic dopamine model of psychosis. |
2009-02-03 |
2023-08-12 |
Not clear |
| Kirill A Martemyanov, Claudia M Krispel, Polina V Lishko, Marie E Burns, Vadim Y Arshavsk. Functional comparison of RGS9 splice isoforms in a living cell. Proceedings of the National Academy of Sciences of the United States of America. vol 105. issue 52. 2009-01-27. PMID:19098104. |
rgs9-1 regulates phototransduction in rods and cones, and rgs9-2 regulates dopamine and opioid signaling in the basal ganglia. |
2009-01-27 |
2023-08-12 |
mouse |
| Yoshihiro Takeuch. [Neurotransmission in developmental disorders]. No to hattatsu = Brain and development. vol 40. issue 6. 2009-01-07. PMID:19039985. |
the neurotransmission of dopamine in subcortical regions such as the basal ganglia and limbic areas is synaptic; on the other hand, dopamine neurotransmission in the frontal cortex is quite different, because there are very few dopamine transporters (dat) in the frontal cortex that allow dopamine to diffuse away from the dopamine synapse ("volume transmission"). |
2009-01-07 |
2023-08-12 |
Not clear |
| S Dethy, A S Hamby. [1231-FP-CIT (DaTSCAN) scintigraphy in the differential diagnosis of movement disorders]. Revue medicale de Bruxelles. vol 29. issue 4. 2008-12-31. PMID:18949971. |
the introduction of new isotopic functional imaging techniques, and more specifically the labelling of dopamine transporter derivatives, has improved the understanding and early detection of some diseases affecting the basal ganglia. |
2008-12-31 |
2023-08-12 |
Not clear |
| Maria C Olianas, Simona Dedoni, Marianna Boi, Pierluigi Onal. Activation of nociceptin/orphanin FQ-NOP receptor system inhibits tyrosine hydroxylase phosphorylation, dopamine synthesis, and dopamine D(1) receptor signaling in rat nucleus accumbens and dorsal striatum. Journal of neurochemistry. vol 107. issue 2. 2008-12-24. PMID:18717817. |
nociceptin/orphanin fq (n/ofq) has been reported to inhibit dopamine (da) release in basal ganglia mainly by acting on nop receptors in substantia nigra and ventral tegmental area. |
2008-12-24 |
2023-08-12 |
rat |
| Catherine R G Jones, Tim J L Malone, Georg Dirnberger, Mark Edwards, Marjan Jahanshah. Basal ganglia, dopamine and temporal processing: performance on three timing tasks on and off medication in Parkinson's disease. Brain and cognition. vol 68. issue 1. 2008-12-22. PMID:18378374. |
basal ganglia, dopamine and temporal processing: performance on three timing tasks on and off medication in parkinson's disease. |
2008-12-22 |
2023-08-12 |
Not clear |
| Catherine R G Jones, Tim J L Malone, Georg Dirnberger, Mark Edwards, Marjan Jahanshah. Basal ganglia, dopamine and temporal processing: performance on three timing tasks on and off medication in Parkinson's disease. Brain and cognition. vol 68. issue 1. 2008-12-22. PMID:18378374. |
a pervasive hypothesis in the timing literature is that temporal processing in the milliseconds and seconds range engages the basal ganglia and is modulated by dopamine. |
2008-12-22 |
2023-08-12 |
Not clear |
| Francisco Mora, Gregorio Segovia, Alberto Del Arc. Glutamate-dopamine-GABA interactions in the aging basal ganglia. Brain research reviews. vol 58. issue 2. 2008-12-18. PMID:18036669. |
in this review we focus mostly on our own results on the interaction of the neurotransmitters glutamate, dopamine and gaba in the basal ganglia during the normal process of aging. |
2008-12-18 |
2023-08-12 |
rat |
| R Sanchez-Pernaute, J-Q Wang, D Kuruppu, L Cao, W Tueckmantel, A Kozikowski, O Isacson, A-L Brownel. Enhanced binding of metabotropic glutamate receptor type 5 (mGluR5) PET tracers in the brain of parkinsonian primates. NeuroImage. vol 42. issue 1. 2008-12-08. PMID:18501638. |
the interplay between dopamine and glutamate in the basal ganglia regulates critical aspects of motor learning and behavior. |
2008-12-08 |
2023-08-12 |
Not clear |
| Linda Chang, Gene-Jack Wang, Nora D Volkow, Thomas Ernst, Frank Telang, Jean Logan, Joanna S Fowle. Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse. NeuroImage. vol 42. issue 2. 2008-12-08. PMID:18579413. |
decreased dopamine transporters (dat) in the basal ganglia were shown in patients with human immunodeficiency virus (hiv) associated dementia. |
2008-12-08 |
2023-08-12 |
human |
| Diane L Santesso, Daniel G Dillon, Jeffrey L Birk, Avram J Holmes, Elena Goetz, Ryan Bogdan, Diego A Pizzagall. Individual differences in reinforcement learning: behavioral, electrophysiological, and neuroimaging correlates. NeuroImage. vol 42. issue 2. 2008-12-08. PMID:18595740. |
during reinforcement learning, phasic modulations of activity in midbrain dopamine neurons are conveyed to the dorsal anterior cingulate cortex (dacc) and basal ganglia (bg) and serve to guide adaptive responding. |
2008-12-08 |
2023-08-12 |
human |
| D Domenger, R K W Schwartin. Effects of neostriatal 6-OHDA lesion on performance in a rat sequential reaction time task. Neuroscience letters. vol 444. issue 3. 2008-12-03. PMID:18760328. |
work in humans and monkeys has provided evidence that the basal ganglia, and the neurotransmitter dopamine therein, play an important role for sequential learning and performance. |
2008-12-03 |
2023-08-12 |
human |
| Okihide Hikosaka, Ethan Bromberg-Martin, Simon Hong, Masayuki Matsumot. New insights on the subcortical representation of reward. Current opinion in neurobiology. vol 18. issue 2. 2008-12-02. PMID:18674617. |
midbrain dopamine neurons modulate these basal ganglia neurons differentially using signals related to reward-prediction error. |
2008-12-02 |
2023-08-12 |
Not clear |
| Colleen M Niswender, Kari A Johnson, C David Weaver, Carrie K Jones, Zixiu Xiang, Qingwei Luo, Alice L Rodriguez, Joy E Marlo, Tomas de Paulis, Analisa D Thompson, Emily L Days, Tasha Nalywajko, Cheryl A Austin, Michael Baxter Williams, Jennifer E Ayala, Richard Williams, Craig W Lindsley, P Jeffrey Con. Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4. Molecular pharmacology. vol 74. issue 5. 2008-11-17. PMID:18664603. |
parkinson's disease (pd) is caused by the death of dopamine neurons in the basal ganglia and results in motor symptoms such as tremor and bradykinesia. |
2008-11-17 |
2023-08-12 |
human |
| Massimiliano Di Filippo, Barbara Picconi, Alessandro Tozzi, Veronica Ghiglieri, Aroldo Rossi, Paolo Calabres. The endocannabinoid system in Parkinson's disease. Current pharmaceutical design. vol 14. issue 23. 2008-11-17. PMID:18781984. |
the evidence that ecbs play a central role in regulating basal ganglia physiology and motor function and the profound modifications occurring in ecb signaling after dopamine depletion in both experimental models of pd and patients suffering from the disease, provide support for the development of pharmacological compounds targeting the ecb system as symptomatic and neuroprotective therapeutic strategies for pd. |
2008-11-17 |
2023-08-12 |
Not clear |
| Kenta Sato, Chiho Sumi-Ichinose, Ryuji Kaji, Kazuhisa Ikemoto, Takahide Nomura, Ikuko Nagatsu, Hiroshi Ichinose, Masayuki Ito, Wataru Sako, Shinji Nagahiro, Ann M Graybiel, Satoshi Got. Differential involvement of striosome and matrix dopamine systems in a transgenic model of dopa-responsive dystonia. Proceedings of the National Academy of Sciences of the United States of America. vol 105. issue 34. 2008-10-24. PMID:18713855. |
the mechanisms underlying the genesis of dystonia in drd present a challenge to models of basal ganglia movement control, given that striatal dopamine deficiency is the hallmark of parkinson's disease. |
2008-10-24 |
2023-08-12 |
mouse |
| Bhooma R Aravamuthan, Debra A Bergstrom, Robin A French, Joseph J Taylor, Louise C Parr-Brownlie, Judith R Walter. Altered neuronal activity relationships between the pedunculopontine nucleus and motor cortex in a rodent model of Parkinson's disease. Experimental neurology. vol 213. issue 2. 2008-10-08. PMID:18601924. |
the anesthetized rat is a useful model for investigating the effects of dopamine loss on the transmission of oscillatory cortical activity through basal ganglia structures. |
2008-10-08 |
2023-08-12 |
rat |